Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.

Eitemau Tebyg

• The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: a cluster randomised sub-study
  gan: Farmer, A, et al.
  Cyhoeddwyd: (2016)
• Economic evaluation of factorial trials: cost-utility analysis of the AFORRD 2x2x2 factorial trial of atorvastatin, omega-3 fish oil and action-planning
  gan: Dakin, HA, et al.
  Cyhoeddwyd: (2020)
• Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.
  gan: Neil, H, et al.
  Cyhoeddwyd: (2010)
• Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: A randomised placebo controlled factorial trial
  gan: Neil, H, et al.
  Cyhoeddwyd: (2010)
• Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes.
  gan: Hartweg, J, et al.
  Cyhoeddwyd: (2009)